IRBESARTAN/HCT SANDOZ 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 150/12.5 irbesartan 150 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

sandoz pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: purified talc; hypromellose; lactose monohydrate; iron oxide red; titanium dioxide; microcrystalline cellulose; croscarmellose sodium; iron oxide yellow; macrogol 6000; hyprolose; magnesium stearate; colloidal anhydrous silica - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

IRBESARTAN/HCT SANDOZ 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

irbesartan/hct sandoz 300/12.5 irbesartan 300 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

sandoz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; lactose monohydrate; hyprolose; titanium dioxide; croscarmellose sodium; colloidal anhydrous silica; macrogol 6000; purified talc; microcrystalline cellulose; iron oxide red; iron oxide yellow - irbesartan/hct sandoz is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

CO-DIOVAN 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; iron oxide red; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; macrogol 8000; magnesium stearate; hypromellose; colloidal anhydrous silica - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; iron oxide yellow; colloidal anhydrous silica; crospovidone; purified talc; magnesium stearate; hypromellose; macrogol 8000; iron oxide red; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

QUINATE quinine sulfate dihydrate 300mg tablet jar (reformulation) Australia - English - Department of Health (Therapeutic Goods Administration)

quinate quinine sulfate dihydrate 300mg tablet jar (reformulation)

arrotex pharmaceuticals pty ltd - quinine sulfate dihydrate, quantity: 300 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; sodium starch glycollate; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - prevention and symptomatic relief of muscle cramps. symptomatic relief of myotonia congenita. suppression of malaria. indications as at 21 january 2004. suppression of malaria. indications as at 26 april 2004. suppression of malaria.

ABISART HCTZ 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

abisart hctz 300/25 irbesartan 300 mg + hydrochlorothiazide 25 mg tablet blister pack

sun pharma anz pty ltd - hydrochlorothiazide, quantity: 25 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; hypromellose; lactose monohydrate; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide red; macrogol 4000; iron oxide black; macrogol 400 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

ABISART HCTZ 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

abisart hctz 300/12.5 irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet blister pack

sun pharma anz pty ltd - irbesartan, quantity: 300 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; iron oxide yellow; hypromellose; titanium dioxide; purified talc; macrogol 4000; macrogol 400 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

ABISART HCTZ 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

abisart hctz 150/12.5 irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet blister pack

sun pharma anz pty ltd - irbesartan, quantity: 150 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; lactose monohydrate; hypromellose; croscarmellose sodium; titanium dioxide; purified talc; iron oxide red; macrogol 4000; iron oxide black; macrogol 400 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Burinex 1mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

burinex 1mg tablet blister pack

aft pharmaceuticals pty ltd - bumetanide, quantity: 1 mg - tablet, uncoated - excipient ingredients: agar; lactose monohydrate; maize starch; colloidal anhydrous silica; povidone; polysorbate 80; magnesium stearate; purified talc - burinex is indicated for the treatment of oedema, particularly that associated with congestive heart failure, hepatic and renal diseases including the nephrotic syndrome and acute pulmonary oedema.